SCIENCE@home

Variation in Colonoscopy Performance Measures According to Procedure Indication.

C. Mangas-Sanjuán,E. Santana,J. Cubiella,E. Rodríguez-Camacho,A. Seoane,M. Álvarez-González,A. Suárez,Verónica Álvarez-García,N. Gonzalez,A. Lué,L. Cid-Gómez,Marta Ponce,L. Bujanda,I. Portillo,M. Pellisé,P. Díez-Redondo,M. Herraiz,Akiko Ono,Á. Pizarro,P. Zapater,R. Jover,C. Mangas-Sanjuán,J. Casellas,F. Ruiz-Gómez,E. Serrano,C. Mira,Olegario Castaño,L. Blanco,J. Lara,E. Quintero,H. Clínic,L. Rivero,J. Llach,H. Córdova,I. Araujo,Ariadna Sánchez,I. Ordás,Karina Lisette,H. del Mar,M. Álvarez-González,Laura Carot,I. Ibáñez,Faust Riu,M. Pantaleón,J. Dedeu,L. Barranco,Akiko Ono,F. Baiocchi,C. Tejido,I. Idigoras,I. Bilbao,C. Carretero,M. Betés,Marta Ponce,M. Bustamante,V. Pons,L. Argüello,C. Satorres,H. Núñez,Victoria Busto,L. Cid-Gómez,V. Hernández,Luisa de Castro,Nereida Fernández-Fernández,A. Martínez-Turnes,Beatriz Romero-Mosquera,Romina Fernández-Poceiro,A. Lué,Á. Lanas,Á. Ferrández,P. Roncales

Published 2020 in Clinical Gastroenterology and Hepatology

ABSTRACT

BACKGROUND & AIMS Most fulfillment and benchmarking information for colonoscopy quality indicators has been obtained from studies of primary screening colonoscopies. We analyzed differences in the fulfillment of colonoscopy quality indicators based on indication for endoscopy. METHODS We performed an observational, multicenter, cross-sectional study of 14,867 patients who underwent endoscopy procedures for gastrointestinal symptoms (40.3%), a positive result from a fecal immunochemical test (36.0%), post-polypectomy surveillance (15.3%), or primary screening (8.4%), from February 2016 through December 2017 at 14 centers in Spain. We evaluated rates of adequate colon cleansing, cecal intubation, adenoma detection, and colorectal cancer detection, among others. We used findings from primary screening colonoscopies as the reference standard. RESULTS Fewer than 90% of patients had adequate bowel preparation; 83.1% of patients with gastrointestinal symptoms had adequate bowel preparation (odds ratio [OR] compared to patients with primary screening colonoscopies, 0.62; 95% CI, 0.49-0.78) and 85.3% of patients receiving post-polypectomy surveillance had adequate bowel preparation (OR, 0.71; 95% CI, 0.55-0.91). The cecal intubation rate was also lower in patients with gastrointestinal symptoms (93.1%) (OR, 0.34; 95% CI, 0.22-0.52). The adenoma detection rate was higher in patients with a positive result from a fecal immunochemical test (46.4%) (OR, 2.01; 95% CI, 1.71-2.35) and in patients undergoing post-polypectomy surveillance (48.2%) (OR, 1.41; 95% CI, 1.20-1.67). The highest proportion of patients with colorectal cancer was in the gastrointestinal symptom group (5.1%) (OR, 5.24; 95% CI, 2.30-11.93) and the lowest was in patients undergoing surveillance (0.8%) (OR, 0.83; 95% CI, 0.32-2.14). CONCLUSIONS Fulfillment of colonoscopy performance measures varies substantially by indication. Policies addressing performance measures beyond colonoscopy screening procedures should be developed. Benchmarking recommendations could be adjusted according to colonoscopy indication.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-25 of 25 references · Page 1 of 1

CITED BY

Showing 1-29 of 29 citing papers · Page 1 of 1